Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
APT MedicalSHSE:688617 -1.35%78 FCF Margin % is 40.55% as of Jun. 2026, which is 799% above its 10-year median of 4.51. GuruFocus rates SHSE:688617 with a GF Score™ of 78/100 and a GF Value™ of ¥366.17 (Significantly Undervalued). The stock has 1 warning sign investors should review. Among 812 Medical Devices & Instruments companies, APT Medical ranks better than 97.41% on this metric.
FCF Margin % is calculated as Free Cash Flow divided by its Revenue. APT Medical's Free Cash Flow for the
three
months ended in Jun. 2026 was ¥333 Mil. APT Medical's Revenue for the
three
months ended in Jun. 2026 was ¥822 Mil. Therefore, APT Medical's FCF Margin % for the quarter that ended in Jun. 2026 was 40.55%.
The historical rank and industry rank for APT Medical's FCF Margin % or its related term are showing as below:
SHSE:688617'
s FCF Margin % Range Over the Past 10 Years
Min: -8.06 Med: 4.51 Max: 29.52
Current: 29.52
During the past 9 years, the highest FCF Margin % of APT Medical was 29.52%. The lowest was -8.06%. And the median was 4.51%.
SHSE:688617's FCF Margin % is ranked better than 97.41% of 812
companies
in the Medical Devices & Instruments industry
Industry Median: -0.505
vs SHSE:688617: 29.52
The historical data trend for APT Medical's FCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SHSE:688617 vs ABT, SYK, MDT: FCF Margin % Comparison
For the Medical Devices subindustry, APT Medical's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
APT Medical FCF Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, APT Medical's FCF Margin % distribution charts can be found below:
* The bar in red indicates where APT Medical's FCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
APT Medical (SHSE:688617) has a FCF Margin % of 40.55% as of Jun. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on APT Medical and its competitors. This is 799% above median its historical median of 4.51. According to the industry distribution chart, APT Medical ranks #21 out of 812 companies in the Medical Devices & Instruments industry, placing it in the top 2.6%.
Is APT Medical's FCF Margin % too high?
APT Medical's current FCF Margin % of 40.55% is 799% above median its 10-year median of 4.51. Based on the distribution chart, APT Medical ranks #21 out of 812 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, APT Medical has a GF Score™ of 78/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does APT Medical's FCF Margin % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, APT Medical ranks #21 out of 812 companies for FCF Margin %. This places APT Medical in the top 3% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Medical Devices & Instruments company?
A good FCF Margin % depends on the Medical Devices & Instruments industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on APT Medical and its competitors. APT Medical's current FCF Margin % is 40.55%, which is 799% above median its own 10-year median of 4.51. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is APT Medical stock overvalued right now?
Based on GuruFocus' analysis, APT Medical (SHSE:688617) is currently considered Significantly Undervalued. The stock's GF Value™ is ¥366.17, compared to a current price of ¥239.60 — trading 34.6% below its estimated fair value. The current FCF Margin % is 40.55%, which is 799% above median its 10-year median of 4.51. APT Medical's overall GF Score™ is 78/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For APT Medical (SHSE:688617), the current FCF Margin % is 40.55% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is APT Medical (SHSE:688617) Overvalued in 2026?
Based on GuruFocus' analysis, APT Medical stock appears to be undervalued.
The current stock price of ¥239.60 is trading 34.6% below its estimated GF Value™ of ¥366.17.
GuruFocus considers APT Medical to be Significantly Undervalued.
Key valuation signals for SHSE:688617:
FCF Margin %: 40.55% (799% above median its 10-year median of 4.51)
GF Value™: ¥366.17 vs. price of ¥239.60 (34.6% below fair value)
No single metric tells the full story. See the SHSE:688617 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
APT Medical Inc is engaged in the research and development, production and sales of electrophysiological and vascular interventional medical devices for cardiovascular and cerebrovascular diseases. Its products are sold in Europe, Eastern Europe, Southeast Asia and other countries and other regions.
78GF Score
Get the complete analysis for SHSE:688617
FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:688617 has been successfully added to your 
